placebo [clinicaltrials_resource:ba39872c505521770170b76e7dc36eda]
Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes (RAPSODI) [clinicaltrials:NCT00325650]Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) [clinicaltrials:NCT00358878]Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver [clinicaltrials:NCT00359437]Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver [clinicaltrials:NCT00366795]Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS) [clinicaltrials:NCT00434096]
intervention [clinicaltrials_vocabulary:intervention]
placebo [clinicaltrials_resource:ba39872c505521770170b76e7dc36eda]
Bio2RDF identifier
ba39872c505521770170b76e7dc36eda
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ba39872c505521770170b76e7dc36eda
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
oral administration once daily
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:ba39872c505521770170b76e7dc36eda
title
placebo
@en
type
label
placebo [clinicaltrials_resource:ba39872c505521770170b76e7dc36eda]
@en